October 11, 2013

FDA Approves Sanofi’s Nasacort® Allergy 24HR for Over-the-Counter Use

Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies

 

FDA Approves Sanofi’s Nasacort® Allergy 24HR for Over-the-Counter Use
Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies

Paris, France, October 11, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort® Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. Nasacort is the first and only medicine in its class to be available without a prescription and will be marketed by Sanofi’s consumer healthcare division in the United States, Chattem, Inc.